Exiqon
Home Search Contact Print Mobile
Products Services Applications Resource Center Ordering About Exiqon Investor
microRNA Research
RNA Research
DNA Research
Custom Oligos
Other Reagents
RNA Isolation
Microarray Analysis
Real-time PCR
Northern Blotting
In Situ Hybridization
Functional Analysis
RNA Preparation
Microarray analysis
Real-time PCR
In Situ Hybridization
Antisense
SNP Detection
Microarray Analysis
In Situ Hybridization
LNA Phosphoramidites
AQ-link Products
A2 Quencher
RNA Isolation Services
microRNA Array Services
microRNA PCR Services
microRNA ISH Services
Isolation
Microarray Analysis
Northern Blotting
Real-time PCR
In Situ Hybridization
Functional Analysis
SNP Detection
RNA
microRNA
RNA
DNA
microRNA
microRNA
mRNA
microRNA
Other RNAs
DNA
microRNA
RNA
DNA
MicroRNA Research
RNA Research
Other reagents
Technology Base
Oligo design tools
Exiqon E-talk
Research Guide
Array Downloads
qPCR Data Analysis
Technical Literature and Manuals
Scientific Publications
Application Stories
Bioinformatics
Technical Literature and Manuals
Scientific Publications
Application Stories
Bioinformatics
Technical Literature and Manuals
Scientific Publications
Oligo modifications
LNA™
AQ-link
Order microRNA products
Order custom oligos
Distributors
General Information
Contact
Company profile
Sign up to Newsletter
Newsletter Back Issues
Investor Relations
Media
Announcements
Financials
Guidelines for Incentive Pay
Corporate Governance
Investor Signup
Contact Us
Share Info
Calendar
Reports
Figures
Analysts
Presentations
Contact
Tal og fakta
Samarbejdspartnere
IR Policy
Articles of Association

Analyst Coverage

Exiqon A/S is covered by the analysts listed below. Brokerage firms may decide at any time to terminate or commence coverage of Exiqon A/S stock. Please note that any opinions, estimates or forecasts regarding Exiqon's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Exiqon A/S or its management. Exiqon A/S is providing this list for the convenience of its investors and does not by its reference below or distribution imply, and expressly disclaims, any endorsement of or concurrence with any information, estimates, forecasts, opinions, conclusions or recommendations provided by these analysts. Other research analysts may institute coverage or publish opinions and recommendations from time to time, and Exiqon A/s expressly disclaims any obligation to update the information contained herein. 

Exiqon Analysts


Handelsbanken Capital Markets
Michael Novod
Pharmaceuticals & Biotech, Equity & Credit Research
Havneholmen 29
1561 Copenhagen V
Denmark
Phone: +45 3341 8618
Mobile: +45 2972 0161
Fax: +45 3341 8552
E-mail: mino03@handelsbanken.dk
http://www.handelsbanken.com/capitalmarkets

Danske Markets Equities
Thomas Bowers
Holmens Kanal 2-12
1092 Copenhagen K
Phone: +45 4512 8044
e-mail: thomas.bowers@danskebank.com
www.danskeequities.com

  Privacy   Sitemap   Legal